Literature DB >> 16421515

DHEA, a neurosteroid, decreases cocaine self-administration and reinstatement of cocaine-seeking behavior in rats.

Ravid Doron1, Lilach Fridman, Iris Gispan-Herman, Rachel Maayan, Abraham Weizman, Gal Yadid.   

Abstract

Dehydroepiandrosterone (DHEA), which can act as a potential antidepressant in both animals and humans, appears to lower distress involved with cocaine withdrawal. In fact, a role for neurosteroids in modulation of substance-seeking behavior is becoming increasingly clear. Therefore, we tested the effects of DHEA on the self-administration of cocaine (1 mg/kg/infusion) by rats. At maintenance, a relatively low dose of exogenous DHEA (2 mg/kg; i.p.) attenuated cocaine self-administration after several days of chronic treatment. More than 2 weeks (19 days) of daily DHEA injections were required to decrease the cocaine-seeking behavior of rats to less than 20% of their maintenance levels. DHEA does not seem to decrease cocaine self-administration by increasing the reinforcing properties of the drug, as indicated by a cocaine dose-response determination. After being subjected to extinction conditions in the presence of DHEA, rats demonstrated a minimal response to acute exposure to cocaine (10 mg/kg), which indicated a protective effect of DHEA on relapse to cocaine usage. Our results suggest a potential role for the neurosteroid DHEA in controlling cocaine-seeking behavior, by reducing both the desire for cocaine usage and the incidence of relapse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421515     DOI: 10.1038/sj.npp.1301013

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  12 in total

1.  Adolescent rats are protected from the conditioned aversive properties of cocaine and lithium chloride.

Authors:  Nicole L Schramm-Sapyta; Richard W Morris; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2006-07-03       Impact factor: 3.533

2.  Neuroactive steroid levels and cocaine use chronicity in men and women with cocaine use disorder receiving progesterone or placebo.

Authors:  Verica Milivojevic; Jonathan Covault; Gustavo A Angarita; Kristen Siedlarz; Rajita Sinha
Journal:  Am J Addict       Date:  2018-12-11

Review 3.  Substance abuse in women.

Authors:  Shelly F Greenfield; Sudie E Back; Katie Lawson; Kathleen T Brady
Journal:  Psychiatr Clin North Am       Date:  2010-06

4.  Social evaluative threat with verbal performance feedback alters neuroendocrine response to stress.

Authors:  Jenny M Phan; Ekaterina Schneider; Jeremy Peres; Olga Miocevic; Vanessa Meyer; Elizabeth A Shirtcliff
Journal:  Horm Behav       Date:  2017-09-21       Impact factor: 3.587

Review 5.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

Review 6.  Anti-relapse medications: preclinical models for drug addiction treatment.

Authors:  Noushin Yahyavi-Firouz-Abadi; Ronald E See
Journal:  Pharmacol Ther       Date:  2009-08-13       Impact factor: 12.310

7.  Addiction and the adrenal cortex.

Authors:  Gavin P Vinson; Caroline H Brennan
Journal:  Endocr Connect       Date:  2013-05-31       Impact factor: 3.335

Review 8.  Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking.

Authors:  Erin L Martin; Elizabeth M Doncheck; Carmela M Reichel; Aimee L McRae-Clark
Journal:  Neurobiol Stress       Date:  2021-07-10

9.  Modulation of mood States as a major factor in relapse to substance use.

Authors:  Gal Yadid; Lior Redlus; Royi Barnea; Ravid Doron
Journal:  Front Mol Neurosci       Date:  2012-07-23       Impact factor: 5.639

Review 10.  Substance use in women: Current status and future directions.

Authors:  Rakesh Lal; Koushik Sinha Deb; Swati Kedia
Journal:  Indian J Psychiatry       Date:  2015-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.